|Articles|January 1, 2016
- Pharmaceutical Executive-01-01-2016
- Volume 36
- Issue 1
Pharmaceutical Executive, January 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Feeling the Heat: Pharm Exec's 2016 Industry Forecastover 9 years ago
Ferring: The Quiet Companyalmost 10 years ago
Feel the Earth Move Under Your Brand?almost 10 years ago
Is the Hatch-Waxman System Broken?almost 10 years ago
2015 FDA Drug Approvalsalmost 10 years ago
Rough Road Ahead for Innovationalmost 10 years ago
Country Report: Puerto RicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
